Evidence map›Paper›PMID 42165710›Full record

ArticleCancer discovery2026

Asynchronous Evolution of Epithelium and Stroma Differentiates Precursor Lesions from Pancreatic Cancer.

Ahmed M Elhossiny, Padma Kadiyala, Jude O Okoye, Harrison L Hiraki, Megan C Procario, Thejaswini Giridharan, Hannah R Watkoske, Mariana Tannus Ruckert, Jiayue Wang, Brian D Griffith and 17 more

Abstract read
In one paragraph

Article in Cancer discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Ahmed M ElhossinyDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-0884-8754
Padma KadiyalaDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-3273-9905
Jude O OkoyeDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-7194-5592
Harrison L HirakiDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-6199-0744
Megan C ProcarioDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-2501-2548
Thejaswini GiridharanDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-0512-577X
Hannah R WatkoskeDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-2518-6457
Mariana Tannus RuckertDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-8282-4454
Jiayue WangDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0006-1005-0652
Brian D GriffithDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-6580-7217
Alexander W BrayDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-1849-2555
Jamie N MillsDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-3360-2254
Carlos E EspinozaDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0000-0460-1514
Jörg ZellerDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0004-0811-8588
Nicole PetersonDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0000-6035-4124
Filip BednarDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-5193-9817
Yaqing ZhangDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9185-4364
Arvind RaoDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9613-426X
Costas A LyssiotisDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-9309-6141
Julianne M SzczepanskiDepartment of Pathology & Clinical Labs, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-5687-9857
Jiaqi ShiRogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-4893-1587
Atul DeshpandeDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0001-5144-6924
Anirban MaitraDepartment of Pathology, NYU Grossman School of Medicine, New York University, New York, New York.ORCID 0000-0001-7923-9978
Elana J FertigInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland.ORCID 0000-0003-3204-342X
Eileen S CarpenterRogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-6775-6943
Timothy L FrankelDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-5987-0404
Marina Pasca di MaglianoDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-9632-9035

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic CancerU54CA274371 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Marina Pasca Di Magliano · 2022 to 2026
$9.5M
Training Program in Tumor MicroenvironmentT32CA009676 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro, Analisa Virginia DiFeo · 1992 to 2026
$7.3M
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)U24CA274274 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI J. Jack LEE, ANIRBAN MAITRA · 2022 to 2026
$4.9M
Fibroblast orchestration of the immune response in pancreatic cancerU01CA274154 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Howard C. Crawford, Timothy Louis Frankel · 2022 to 2026
$4.2M
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.R01CA271510 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Filip Bednar, Marina Pasca Di Magliano · 2022 to 2026
$2.6M
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesisR01CA268426 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Timothy Louis Frankel, Marina Pasca Di Magliano · 2023 to 2026
$2.5M
Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironmentR01CA275182 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Benjamin Allen, Marina Pasca Di Magliano · 2023 to 2026
$2.4M
Defining epigenetic signaling to reshape pancreatic tumor microenvironmentR37CA262209 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jiaqi Shi · 2022 to 2026
$2.3M
Informing mechanistic rules of agent-based models with single-cell multi-omicsU24CA284156 · NCI · TRUSTEES OF INDIANA UNIVERSITY · PI Elana Fertig, Paul T Macklin · 2024 to 2026
$2.3M
Epithelial-immune cell crosstalk during injury and recovery in acute pancreatitisR01DK128102 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Timothy Louis Frankel · 2022 to 2026
$2.2M
Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer.R01CA290780 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Yaqing Zhang, Bin Zheng · 2024 to 2026
$2.0M
BLRD VA I01 BX005777Horace H. Rackham School of Graduate Studies, University of Michigan (Rackham U-M) Rackham International Student FellowshipHorace H. Rackham School of Graduate Studies, University of Michigan (Rackham U-M) Rackham Predoctoral FellowshipNational Cancer Institute (NCI) P30CA046592National Cancer Institute (NCI) R01CA268426National Cancer Institute (NCI) R01CA271510National Cancer Institute (NCI) R01CA275182National Cancer Institute (NCI) R01CA290780National Cancer Institute (NCI) R37CA262209National Cancer Institute (NCI) R50CA232985National Cancer Institute (NCI) T32CA009676National Cancer Institute (NCI) U01CA274154National Cancer Institute (NCI) U24CA274274National Cancer Institute (NCI) U24CA284156National Cancer Institute (NCI) U54CA274371National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5R01DK128102NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA268426NCI NIH HHS R01 CA271510NCI NIH HHS R01 CA275182NCI NIH HHS R01 CA290780NCI NIH HHS R37 CA262209NCI NIH HHS R50 CA232985NCI NIH HHS T32 CA009676NCI NIH HHS U01 CA274154NCI NIH HHS U24 CA274274NCI NIH HHS U24 CA284156NCI NIH HHS U54 CA274371NIDDK NIH HHS R01 DK128102U.S. Department of Veterans Affairs (VA) 5I01BX005777U.S. Department of Veterans Affairs (VA) IK2BX0058
6 · The paper itself

Abstract

Pancreatic intraepithelial neoplasia (PanIN) precedes pancreatic cancer, a deadly disease characterized by an extensive tumor microenvironment. How the microenvironment evolves during cancer progression is largely unknown, as PanINs are microscopic and nondiseased pancreas samples are exceedingly rare, while adjacent normal samples are disrupted by the presence of malignancy. Leveraging donor organs and spatial technologies, we mapped the evolution of PanIN to cancer. The PanIN epithelial component falls on a continuum with cancer, whereas the PanIN microenvironment is drastically distinct. Progression to cancer is accompanied by profound geographic reorganization of myeloid cells and lymphocytes and the formation of a cancer-specific fibroblast population characterized by high levels of smooth muscle actin, LRRC15, and the WNT signaling component LEF1. Together, our data show asynchronous evolution of epithelial and stromal components during pancreatic carcinogenesis. Lack of stromal reprogramming might explain why most PanINs do not progress to cancer. Compiled data available at https://www.pancreas-precancer-atlas.com/. SIGNIFICANCE: Pancreatic cancer precursor lesions are widely prevalent in the population, but progression to invasive cancer is uncommon. Identifying barriers to cancer progression is critical for cancer interception. Our findings describe unique features of the precancer microenvironment that are likely responsible for keeping precursor lesions from progressing to malignancy.

Indexed as

Carcinoma in SituPancreatic NeoplasmsPrecancerous ConditionsAnimalsDisease ProgressionEpitheliumHumansStromal CellsTumor Microenvironment

Identifiers

PMID42165710
PMCPMC13628107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.